The Pattern of Cervical Cancer according to HIV Status in Yaoundé, Cameroon

Author:

Tebeu Pierre-Marie123ORCID,Ngou-Mve-Ngou Jean Pierre4,Zingué Laure Leka2,Antaon Jesse Saint Saba23ORCID,Okobalemba Atenguena Etienne5,Dohbit Julius Sama1

Affiliation:

1. Department of Obstetrics and Gynaecology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

2. League of Initiative and Active Research for Women’s Health and Education (LIRASEF), Yaoundé, Cameroon

3. Inters-states Centre for Public Health Training in Central Africa, Brazzaville, Congo

4. Department of Obstetrics & Gynecology, University Hospitals, Libreville, Gabon

5. Department of Internal Medicine, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaoundé, Cameroon

Abstract

Objective. To analyze the epidemiological aspects of invasive cervical cancer according to HIV status. Methods. This was an historical cohort study from January 2010 to April 2017 in three hospitals at the Yaoundé city Capital, Cameroon, after the National Ethics Committee’ approval. We included invasive cervical cancers with documented HIV status. Odds ratios and 95% confidence interval were calculated to assess the association between the different variables and HIV status. Survival was analyzed using the Kaplan–Meier. The level of significance was set up at <5%. Results. Among the overall 213 cervical cancer patients, 56 were HIV+ (24.67%). Factors associated with positive HIV status were age below 40 (OR: 2.03 (1.38–2.67)), celibacy (OR: 2.88 (1.58–4.17)), nonmenopausal status (OR: 2.56 (1.36–3.75)), low parity, primiparity (OR: 2.59 (1.43–3.74)), and for parity with 2–4 children (OR: 2.24 (1.35–3.12)). Concerning the HIV+ patients, tumor was diagnosed late (stages III-IV) (OR: 2.70 (1.43–5.08)), undifferentiated (grade III) (OR: 7.69 (5.80–9.57)), with low median survival (9.83 months vs. 20.10 months). Conclusion. HIV is frequent among cervical cancer patients. In the HIV+ patients, the diagnosis was made at the advanced stage, cells were poorly differentiated, and the prognosis was worse.

Publisher

Hindawi Limited

Subject

Obstetrics and Gynecology

Reference27 articles.

1. Cancer of the cervix uteri;N. Bhatla;International Journal of Gynecology & Obstetrics,2018

2. La lutte contre le cancer du col de l’utérus: guide des pratiques essentielles;OMS

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F. Bray;CA: A Cancer Journal for Clinicians,2018

4. Why do viruses cause cancer? Highlights of the first century of human tumour virology

5. Epidemiology of cervical squamous intraepithelial lesions in HIV infected women in Kenya: a cross-sectional study;P. Memiah;African Journal of Reproductive Health,2015

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria;Infectious Agents and Cancer;2023-11-01

2. Cervical cancer survival times in Africa;Frontiers in Public Health;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3